Chronic Kidney Disease
Chronic Kidney Disease
Part of NephTimes
Advertisement
Charlotte RobinsonHyperkalemia | February 12, 2025
A study compared the risks of cardiovascular events in hospital settings among patients with CKD with and hyperkalemia.
Read More
Charlotte RobinsonChronic Kidney Disease | February 12, 2025
Eli Lilly ended a phase II trial of volenrelaxin in chronic kidney disease "due to a lack of foreseeable clinical benefit."
Victoria SochaChronic Kidney Disease | February 11, 2025
Previous studies suggest a link between CKD and sleep disorders, but the nature of the association is unclear.
Charlotte RobinsonChronic Kidney Disease | February 10, 2025
Using NURTuRE-CKD data, researchers studied kidney outcomes and heterogeneity of risk by primary renal diagnosis.
Charlotte RobinsonChronic Kidney Disease | February 7, 2025
Monlunabant failed in a study of its use in DKD, but Novo Nordisk had positive news about other kidney treatments in 2024.
Charlotte RobinsonWCN 2025 | February 10, 2025
Can SZC help with RAASi maximization without resultant hyperkalemia in patients with HFrEF and CKD?
Charlotte RobinsonChronic Kidney Disease | February 5, 2025
A study assessed the kidney benefits of metabolic surgery compared to GLP-1RA treatment in patients with obesity and CKD.
Victoria SochaChronic Kidney Disease | January 29, 2025
Does the prevalence of cardiovascular-kidney-metabolic syndrome stages vary by social determinants of health?
Charlotte RobinsonChronic Kidney Disease | January 28, 2025
The FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.
Charlotte RobinsonIgA Nephropathy | January 21, 2025
A study examined the clinical relevance of urinary mRNA levels in patients with IgA nephropathy (IgAN).
Victoria SochaAnemia and Kidney Disease | January 23, 2025
A study examined the efficacy and safety of conversion from treatment with the long-acting ESA MPG-EPO to vadadustat.
Charlotte RobinsonGout | January 18, 2025
Researchers examined ULT and the risk of CKD progression among patients with impaired kidney function and gout.
Charlotte RobinsonGout | January 17, 2025
What is the association of gout with CV disease and mortality risk in patients with type 2 diabetes and can CKD modify it?
Charlotte RobinsonDiabetes and Hypertension | January 23, 2025
A secondary analysis of DCP trial data sought to understand the effects of thiazide diuretics on kidney outcomes.
Charlotte RobinsonChronic Kidney Disease | January 9, 2025
Researchers studied the association between chronic kidney disease and postoperative complications.
Charlotte RobinsonChronic Kidney Disease | January 8, 2025
Researchers studied the association of obesity severity and duration with chronic kidney disease incidence.
Charlotte RobinsonChronic Kidney Disease | January 3, 2025
The FDA rejected Zynquista as an add-on to insulin therapy for adults with type 1 diabetes and CKD.
Victoria SochaChronic Kidney Disease | December 31, 2024
A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies.
Charlotte RobinsonChronic Kidney Disease | January 24, 2025
A study examined the association of APOL1 risk variants and genotypes with chronic kidney disease among West Africans.
Charlotte RobinsonChronic Kidney Disease | December 13, 2024
The European label for Ozempic will be updated to include risk reduction for events related to kidney disease.
Advertisement
Advertisement
Advertisement
Latest News

February 13, 2025